Europe
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Practitioners and law firms should keep their eyes peeled for the shortlists for our annual awards
Despite a broader slowdown in US IP partner hiring in 2025, litigation demand drove aggressive lateral expansion at select firms
Sponsored
Sponsored
-
Sponsored by Bugnion SpAStefano Ferro of Bugnion SpA explains the Italian legal position on inventions developed by private entities and those by universities or public research organisations, and suggests companies should consider modifying their most productive researchers’ contracts -
Sponsored by Maiwald Intellectual PropertyClaus Schindele of Maiwald considers the legal complications regarding patent protection in the offshore wind sector, with a particular eye on Germany and the UK
-
Sponsored by Gün and PartnersMutlu Yıldırım Köse and Merve Çimen Sevine of Gün + Partners consider several Turkish decisions protecting copyrighted entertainment works when characters, titles, and associated signs have featured in trademark applications
-
Sponsored by Maiwald Intellectual PropertyKerstin Wolff of Maiwald reports on a proposal that supports the use of some plants generated by new genomic techniques but opposes patents for all plants obtained by such means
-
Sponsored by InspicosA case concerning a payment made after the nine-month opposition period because of a problem with the EPO’s online filing software offers a useful checklist, says Edward Farrington of Inspicos
-
Sponsored by Gün and PartnersSelin Sinem Erciyas and Beste Turan of Gün and Partners explain why the World Trade Organization's response to the EU’s claims regarding Chinese preliminary injunction decisions will have a far-reaching impact
European Jurisdictions